IART
Price
$12.04
Change
-$0.05 (-0.41%)
Updated
Nov 13 closing price
Capitalization
936.26M
103 days until earnings call
Intraday BUY SELL Signals
ISPC
Price
$0.62
Change
-$0.01 (-1.59%)
Updated
Nov 13 closing price
Capitalization
6.06M
Intraday BUY SELL Signals
Interact to see
Advertisement

IART vs ISPC

Header iconIART vs ISPC Comparison
Open Charts IART vs ISPCBanner chart's image
Integra LifeSciences Holdings
Price$12.04
Change-$0.05 (-0.41%)
Volume$861.77K
Capitalization936.26M
iSpecimen
Price$0.62
Change-$0.01 (-1.59%)
Volume$181.4K
Capitalization6.06M
IART vs ISPC Comparison Chart in %
IART
Daily Signal:
Gain/Loss:
ISPC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IART vs. ISPC commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IART is a Hold and ISPC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (IART: $12.09 vs. ISPC: $0.63)
Brand notoriety: IART and ISPC are both not notable
IART represents the Medical/Nursing Services, while ISPC is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IART: 97% vs. ISPC: 1%
Market capitalization -- IART: $936.26M vs. ISPC: $6.06M
IART [@Medical/Nursing Services] is valued at $936.26M. ISPC’s [@Medical Specialties] market capitalization is $6.06M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $224.77B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Medical Specialties] industry is $12.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IART’s FA Score shows that 1 FA rating(s) are green whileISPC’s FA Score has 0 green FA rating(s).

  • IART’s FA Score: 1 green, 4 red.
  • ISPC’s FA Score: 0 green, 5 red.
According to our system of comparison, both IART and ISPC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IART’s TA Score shows that 5 TA indicator(s) are bullish while ISPC’s TA Score has 5 bullish TA indicator(s).

  • IART’s TA Score: 5 bullish, 5 bearish.
  • ISPC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ISPC is a better buy in the short-term than IART.

Price Growth

IART (@Medical/Nursing Services) experienced а +6.05% price change this week, while ISPC (@Medical Specialties) price change was -5.79% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.41%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +6.50%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.12%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

IART is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Medical/Nursing Services (+0.41% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (+1.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($936M) has a higher market cap than ISPC($6.06M). IART YTD gains are higher at: -46.693 vs. ISPC (-76.083). ISPC has higher annual earnings (EBITDA): -8.01M vs. IART (-332.17M). IART has more cash in the bank: 254M vs. ISPC (589K). ISPC has less debt than IART: ISPC (288K) vs IART (2.01B). IART has higher revenues than ISPC: IART (1.62B) vs ISPC (5.91M).
IARTISPCIART / ISPC
Capitalization936M6.06M15,458%
EBITDA-332.17M-8.01M4,145%
Gain YTD-46.693-76.08361%
P/E Ratio66.48N/A-
Revenue1.62B5.91M27,454%
Total Cash254M589K43,124%
Total Debt2.01B288K699,306%
FUNDAMENTALS RATINGS
IART: Fundamental Ratings
IART
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IARTISPC
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 21 days ago
89%
Declines
ODDS (%)
Bearish Trend 10 days ago
75%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IART
Daily Signal:
Gain/Loss:
ISPC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QIORX18.690.15
+0.81%
AQR International Momentum Style R6
EQNVX24.130.10
+0.42%
MFS Equity Income R6
HCMQX22.650.06
+0.27%
HCM Sector Plus I
WGFIX12.400.03
+0.24%
William Blair Global Leaders I
FCASX31.73N/A
N/A
Fidelity Advisor Asset Manager 70% C

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with ENOV. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
-1.95%
ENOV - IART
57%
Loosely correlated
-0.86%
CNMD - IART
54%
Loosely correlated
-2.57%
RVTY - IART
49%
Loosely correlated
-0.19%
AVNS - IART
45%
Loosely correlated
+0.86%
MTD - IART
44%
Loosely correlated
+0.19%
More

ISPC and

Correlation & Price change

A.I.dvisor tells us that ISPC and AEMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISPC and AEMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISPC
1D Price
Change %
ISPC100%
-0.45%
AEMD - ISPC
32%
Poorly correlated
-3.23%
IART - ISPC
29%
Poorly correlated
-1.95%
STXS - ISPC
26%
Poorly correlated
-14.74%
RVTY - ISPC
26%
Poorly correlated
-0.19%
CTSO - ISPC
26%
Poorly correlated
-8.45%
More